基本信息
浏览量:61
职业迁徙
个人简介
My entire career is focused on molecular pharmacology of adult neurodegenerative diseases, with special emphasis on mitochondrial involvement in neurodegeneration. I am a clinician-scientist and have provided clinical care and clinical research in all degenerative adult diseases, with my major focus being Parkinson's disease. I have held several IND's for drug testing and invented the use of R(+) pramipexole (PPX) in brain diseases. I hold an active Physician-Sponsor IND for R(+)PPX. I was Director of the University of Virginia Morris Udall Parkinson's Research Center of Excellence (NIH funded 2000-2010, Director 2008-2010). I was Chair of Neurology at Virginia Commonwealth University 2009-2013 and founding Director of the VCU Parkinson's and Movement Disorders Center 2009-2015. I have retired from academic medicine and started a NFP company (Neurodegeneration Therapeutics, Inc) to pursue laboratory research using induced pluripotential stem cells (iPSC's) from persons with degenerative diseases. Our focus is on "personalized pharmacology" to emphasize treatments for specific individuals as opposed to large groups, which is the traditional paradigm for drug development.
研究兴趣
论文共 125 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
The American Journal of Human Geneticsno. 1 (2021): 8-15
American journal of human geneticsno. 9 (2021): 1809-1810
Journal of Stem Cell Research and Medicineno. 1 (2018)
Journal of Systems and Integrative Neuroscienceno. 6 (2017)
加载更多
作者统计
#Papers: 125
#Citation: 8033
H-Index: 49
G-Index: 88
Sociability: 6
Diversity: 3
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn